1. Factor Xa Inhibition Across the Spectrum of ACS: A New Standard of Care Dr. Ihab Suliman 2. Meta-analysis of UFH and LMWH vs Placebo in UA/NSTEMI Eikelboom J.Lancet2000;355:1936–42…

Slide 1S TANFORD Tirofiban Given in the Emergency Room Before Primary Angioplasty (TIGER-PA) Pilot Study David P. Lee, MD, Alan C. Yeung, MD, Donald Schreiber, MD, Michelle…

Slide 1 La PTCA dopo fibrinolisi: precoce o rescue ? Zoran Olivari Firenze, 23 gennaio 2010 Cardiologia Treviso Slide 2 ESC, 2008 Rescue PCI:in pts with large infarcts if…

Slide 1 Timing of Intervention in Patients with Acute Coronary Syndromes (TIMACS) AHA, 2008 Slide 2 Background For UA/NSTEMI pts that are treated with an invasive strategy,…

Slide 1 Update on the Medical Management of Acute Coronary Syndrome Slide 2 Worldwide Statistics Each year: > 4 million patients are admitted with unstable angina and…

Slide 1 Scranton Heart Institute, P.C. Anti-Platelet Medications For Elective Percutaneous Coronary Interventional Procedures - 2011 Stafford M. Smith, M.D., FACP, FACC Slide…

CURE, HARM and GIM Academic ½ Day October 24th 2001 Dr Hui N. Lee, MD, M.Sc., FRCPC Community GIM, Sault Ste Marie Clinical Assistant Professor McMaster University Objectives…

“Vulnerable” Plaque and Acute Coronary Syndromes Rupture Thrombosis Occlusion Prothrombin Fibrinogen Fibrin monomer Tissue Factor VIIa VII VIIa/TF IX IXa X Xa Fibrin…

Initiating Antiplatelet Therapy in Patients with Atherothrombosis Sunil V. Rao MD Durham VA Medical Center Duke Clinical Research Institute Duke University Medical Center…

Conclusions Clopidogrel significantly reduces the risk of: CV Death, MI, Stroke by about one-fifth (p < 0.001) CV Death, MI, Stroke, and Refractory Ischemia by about one-sixth…